Mumbai/IBNS, Dec. 15 -- Pharmaceutical firm Corona Remedies made a strong debut on the stock market on Monday, listing at a 38% premium over its IPO price on the National Stock Exchange (NSE), media reports said.

The Rs.655.37-crore IPO, which was entirely an offer for sale, had a price band of Rs.1,008-1,062 per share and was open for subscription from December 8 to 10.

Headquartered in Ahmedabad, Gujarat, Corona Remedies is an Indian pharmaceutical company with a strong presence in branded generics, catering to both chronic and acute therapy segments.

Published by HT Digital Content Services with permission from India Blooms....